Birc5 (also known as Survivin) has been implicated in a number of kidney conditions, including autosomal-dominant polycystic kidney disease, acute kidney injury and renal cell carcinomas80–84, however its role in context of normal kidney development is still unknown. Here, BIRC5 is linked to autosomal dominant polycystic kidney disease.